Imagen de Portada

Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Huarui Cai, Hongjuan Cui, Erhu Zhao
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	MedComm – Oncology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Targeting RNA‐binding motif protein 39 for arginine reduction: unveiling metabolic vulnerability in arginine‐dependent liver cancer
por: Aoxue Li, et al.
Publicado: (2024)

Targeting EZH2 in Cancer: From Molecular Mechanisms to Clinical Translation
por: Xi Zhong, et al.
Publicado: (2026)

Targets of tumor microenvironment for potential drug development
por: Ling Zhang, et al.
Publicado: (2024)

Lysosome‐targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins
por: Qingquan Zheng, et al.
Publicado: (2024)

Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
por: Tong Zhang, et al.
Publicado: (2025)

Oxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics
por: Xishan Yang, et al.
Publicado: (2026)

Next‐generation sequencing identifies that protein tyrosine phosphatase receptor type D mutation is favorable to immunotherapy in human cancer
por: Yongsheng Huang, et al.
Publicado: (2024)

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics
por: Han Sun, et al.
Publicado: (2025)

Molecular Glue Degraders Redefining Targeted Therapies From Discovery to Therapeutic Applications
por: Jinfeng Wen, et al.
Publicado: (2026)

Targeting werner helicase with synthetic lethality in microsatellite instability cancers: Promising therapeutic approaches
por: Huanzhang Xie, et al.
Publicado: (2024)

Lomitapide: Targeting METTL3 to Overcome Osimertinib Resistance in NSCLC Through Autophagy Activation
por: Xiaohui Du, et al.
Publicado: (2025)

Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling
por: Zhiqiang Wang, et al.
Publicado: (2024)

KMT2C/D deficiency promotes breast cancer metastasis by regulating KDM6A‐mediated epigenetic remodeling
por: Zhao Huang, et al.
Publicado: (2024)

Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer
por: Nan Liu, et al.
Publicado: (2025)

Multifacet Roles of Cellular Senescence in Cancer: Mechanisms and Therapeutic Implications
por: Huajie Mao, et al.
Publicado: (2026)

Parkinson's Disease and Cancer: Mechanistic Insights and Therapeutic Opportunities From Cancer Neuroscience
por: Tianli Pan, et al.
Publicado: (2025)

Pharmacokinetics comparison of aumolertinib, osimertinib, gefitinib and their major metabolites in mouse model and NSCLC patients
por: Ran Ren, et al.
Publicado: (2024)

Alcohol Dehydrogenase 4‐Mediated Retinol Metabolism Inhibits Hepatocellular Carcinoma Progression Through Inhibiting the Wnt/β‐Catenin Pathway
por: Jiaying Li, et al.
Publicado: (2025)

Colorectal Cancer Cells Promote de novo Glycine Synthesis for Collagen Production in Cancer‐Associated Fibroblasts by Secreting TGF‐β1
por: Chunqi Liu, et al.
Publicado: (2025)

LncRNA SNHG5/miR‐363‐3p/USP28 Axis Promotes Lung Adenocarcinoma Progression Through Enhancing β‐Catenin Stabilization
por: Jia‐yu Zou, et al.
Publicado: (2025)

Construction of a Prediction Model for Thyroid Nodules Based on Machine Learning
por: Siye Gong, et al.
Publicado: (2026)

The Acetyl‐CoA‐NLRX1 Axis Acts as a Key Player in Mitophagy and Drug Resistance
por: Ping Jin, et al.
Publicado: (2026)

Clinical homologous recombination repair gene reversion analysis identifies mechanisms of resistance to PARP inhibitors and platinum‐chemotherapy
por: Yan Jia, et al.
Publicado: (2024)

Issue Information
Publicado: (2024)

CSF@E‐Hn: A bone marrow‐targeted nanosystem for advanced treatment of hematological malignancies
por: Yinyan Jiang, et al.
Publicado: (2024)

The prognostic value of microRNA‐200 family expression in digestive system tumors: A meta‐analysis and validation
por: Xiaoshuang Wu, et al.
Publicado: (2024)

Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
por: Tian‐Hua Wei, et al.
Publicado: (2024)

miRNA interplay: Mechanisms and therapeutic interventions in cancer
por: Zehua Wang, et al.
Publicado: (2024)

Redox regulation of cancer stem cells: Biology and therapeutic implications
por: Min Du, et al.
Publicado: (2024)

Deciphering transcriptional bursts and enhancer dynamics: Advancing cancer therapeutics through single‐cell global run‐on sequencing
por: Xiangyu Pan, et al.
Publicado: (2024)

PGE2‐EP2/EP4 axis: A new perspective on cancer immunotherapy
por: Lin Chen, et al.
Publicado: (2024)

Mechanism and application of acupuncture and electro‐acupuncture associated with cancer therapy
por: Xinggang Yang, et al.
Publicado: (2024)

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges
por: Jie Xu, et al.
Publicado: (2024)

Extracellular vesicles in cancer drug resistance: Mechanistic insights and therapeutic implications
por: Jing Zuo, et al.
Publicado: (2024)

Extensive infiltration of CD8+ T cells and M1 macrophages is beneficial for multiple cancer patients undergoing chemotherapy
por: Yuquan Bai, et al.
Publicado: (2024)

Issue Information
Publicado: (2024)

Alanyl‐tRNA synthetase AARS1: A novel lactate sensor and lactyltransferase mediating p53 lactylation and tumorigenesis
por: Qiqing Yang, et al.
Publicado: (2024)

Pathogenic mechanisms and etiologic aspects of Mycobacterium avium subspecies paratuberculosis as an infectious cause of cutaneous melanoma
por: Ellen S. Pierce, et al.
Publicado: (2024)

The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
por: Meiyi Ge, et al.
Publicado: (2024)

Issue Information
Publicado: (2024)